Zenas Biopharma Announces Upcoming Presentations Of Obexelimab Data In IgG4-Related Disease At The IgG4WARD! 6th International Symposium On IgG4-Related Disease And ACR Convergence 2026
ZBIO•Upcoming presentation announcement
Sept. 22 (Reuters) - Zenas BioPharma, Inc. ZBIO.O:
- Zenas Biopharma announces upcoming presentations of obexelimab data in IgG4-related disease at the IgG4WARD! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026.
